Fig. 2From: The role of stromal immune microenvironment in the progression of ductal carcinoma in situ (DCIS) to invasive breast cancerA The differences in the scores of CD20 + immune cells in the group of 30 patients with primary DCIS and the same 30 patients with ipsilateral breast recurrence (p < 0.001). B The differences in the scores of CD163 + immune cells in the group of 30 patients with primary DCIS, the same 30 patients with ipsilateral breast recurrence (p < 0.001)Back to article page